| Product Code: ETC13311452 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Dengue Vaccines Market was valued at USD 0.7 Billion in 2024 and is expected to reach USD 1.5 Billion by 2031, growing at a compound annual growth rate of 9.10% during the forecast period (2025-2031).
The Global Dengue Vaccines Market is experiencing steady growth driven by the increasing incidence of dengue fever worldwide. With the absence of specific antiviral treatments for dengue, vaccines are becoming crucial in preventing and controlling the spread of the disease. Key players in the market are focusing on research and development initiatives to introduce effective and safe vaccines. Factors such as government initiatives for dengue prevention, growing awareness about vaccination, and the expanding healthcare infrastructure in developing countries are further propelling market growth. The market is characterized by collaborations between pharmaceutical companies and research institutions, as well as strategic partnerships to accelerate vaccine development and commercialization. Overall, the Global Dengue Vaccines Market is poised for significant expansion in the coming years as the global health community intensifies efforts to combat this infectious disease.
The Global Dengue Vaccines Market is experiencing significant growth driven by the increasing prevalence of dengue fever worldwide. Key trends in the market include the development of novel vaccine candidates utilizing advanced technologies such as live attenuated vaccines and recombinant vaccines. Other opportunities in the market stem from the rising awareness about dengue prevention and the government initiatives to control the spread of the disease. Moreover, collaborations between pharmaceutical companies and research institutions for the development of effective vaccines are expected to fuel market growth. The market is also witnessing a surge in investments in research and development activities aimed at introducing new and improved vaccines to address the unmet needs in dengue prevention.
The Global Dengue Vaccines Market faces several challenges, including the need for effective and long-lasting vaccines due to the complexity of the dengue virus and the existence of multiple serotypes. Additionally, the high costs associated with research and development, production, and distribution of vaccines pose a challenge, especially in low- and middle-income countries where dengue is prevalent. Regulatory hurdles, such as varying approval processes across different regions and countries, also impact the market. Furthermore, vaccine hesitancy and lack of awareness about dengue prevention measures hinder the uptake of vaccines. Overall, overcoming these challenges requires collaboration among stakeholders, increased investment in research, and improved access to vaccines in at-risk populations.
The Global Dengue Vaccines Market is primarily driven by the increasing prevalence of dengue fever worldwide, particularly in tropical and subtropical regions. The rising awareness about the importance of vaccination as a preventive measure against dengue, coupled with government initiatives to control the spread of the disease, is also fueling market growth. Additionally, the growing investments in research and development activities to develop more effective and affordable dengue vaccines are driving market expansion. Furthermore, the expanding healthcare infrastructure in developing countries and the rising disposable income levels in emerging economies are expected to contribute to the demand for dengue vaccines. Overall, the market is poised for growth due to the collective efforts of healthcare organizations, governments, and pharmaceutical companies to combat the dengue virus effectively.
Government policies related to the Global Dengue Vaccines Market vary by country. Some governments have implemented vaccination programs to curb the spread of dengue fever, particularly in regions where the disease is endemic. These programs often target high-risk populations such as children and travelers to affected areas. Additionally, government regulatory bodies play a key role in overseeing the approval and distribution of dengue vaccines to ensure their safety and efficacy. Funding support from governments and international organizations also helps in the research and development of dengue vaccines. Overall, government policies aim to promote vaccination coverage, reduce the burden of dengue fever, and protect public health.
The Global Dengue Vaccines Market is poised for significant growth in the coming years as dengue fever continues to be a major public health concern in many regions. With the increasing awareness about the disease and the need for preventive measures, the demand for dengue vaccines is expected to rise. Key market players are investing in research and development to introduce more effective and affordable vaccines, which will further drive market growth. Government initiatives to control dengue outbreaks and the implementation of vaccination programs in endemic areas are also expected to contribute to market expansion. Overall, the Global Dengue Vaccines Market is projected to experience steady growth in the foreseeable future.
The Global Dengue Vaccines Market shows regional variations in terms of adoption and market growth. In Asia, particularly in countries like India and Thailand, there is a high burden of dengue cases, driving the demand for vaccines. North America and Europe are witnessing steady growth due to increasing awareness and government initiatives to control dengue outbreaks. The Middle East and Africa region is expected to show moderate growth, with countries like Brazil in Latin America leading in vaccine development and distribution. Latin America has a long history of dengue outbreaks, prompting governments to invest in preventive measures such as vaccination campaigns. Overall, the Asia-Pacific region dominates the market, followed by Latin America, with other regions showing promising growth potential in the coming years.
Global Dengue Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Dengue Vaccines Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Dengue Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Global Dengue Vaccines Market - Industry Life Cycle |
3.4 Global Dengue Vaccines Market - Porter's Five Forces |
3.5 Global Dengue Vaccines Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Dengue Vaccines Market Revenues & Volume Share, By Vaccine, 2021 & 2031F |
3.7 Global Dengue Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Global Dengue Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Global Dengue Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Dengue Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Dengue Vaccines Market Trends |
6 Global Dengue Vaccines Market, 2021 - 2031 |
6.1 Global Dengue Vaccines Market, Revenues & Volume, By Vaccine, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Dengue Vaccines Market, Revenues & Volume, By Live-Attenuated, 2021 - 2031 |
6.1.3 Global Dengue Vaccines Market, Revenues & Volume, By Inactivated, 2021 - 2031 |
6.2 Global Dengue Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Dengue Vaccines Market, Revenues & Volume, By Pediatrics, 2021 - 2031 |
6.2.3 Global Dengue Vaccines Market, Revenues & Volume, By Adults, 2021 - 2031 |
6.3 Global Dengue Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Dengue Vaccines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Dengue Vaccines Market, Revenues & Volume, By Pharmacies, 2021 - 2031 |
6.4 Global Dengue Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Dengue Vaccines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Dengue Vaccines Market, Revenues & Volume, By Clinics, 2021 - 2031 |
7 North America Dengue Vaccines Market, Overview & Analysis |
7.1 North America Dengue Vaccines Market Revenues & Volume, 2021 - 2031 |
7.2 North America Dengue Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Dengue Vaccines Market, Revenues & Volume, By Vaccine, 2021 - 2031 |
7.4 North America Dengue Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5 North America Dengue Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6 North America Dengue Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Dengue Vaccines Market, Overview & Analysis |
8.1 Latin America (LATAM) Dengue Vaccines Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Dengue Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Dengue Vaccines Market, Revenues & Volume, By Vaccine, 2021 - 2031 |
8.4 Latin America (LATAM) Dengue Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8.5 Latin America (LATAM) Dengue Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8.6 Latin America (LATAM) Dengue Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Dengue Vaccines Market, Overview & Analysis |
9.1 Asia Dengue Vaccines Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Dengue Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Dengue Vaccines Market, Revenues & Volume, By Vaccine, 2021 - 2031 |
9.4 Asia Dengue Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
9.5 Asia Dengue Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9.6 Asia Dengue Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Dengue Vaccines Market, Overview & Analysis |
10.1 Africa Dengue Vaccines Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Dengue Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Dengue Vaccines Market, Revenues & Volume, By Vaccine, 2021 - 2031 |
10.4 Africa Dengue Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
10.5 Africa Dengue Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10.6 Africa Dengue Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Dengue Vaccines Market, Overview & Analysis |
11.1 Europe Dengue Vaccines Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Dengue Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Dengue Vaccines Market, Revenues & Volume, By Vaccine, 2021 - 2031 |
11.4 Europe Dengue Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
11.5 Europe Dengue Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11.6 Europe Dengue Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Dengue Vaccines Market, Overview & Analysis |
12.1 Middle East Dengue Vaccines Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Dengue Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Dengue Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Dengue Vaccines Market, Revenues & Volume, By Vaccine, 2021 - 2031 |
12.4 Middle East Dengue Vaccines Market, Revenues & Volume, By Age Group, 2021 - 2031 |
12.5 Middle East Dengue Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12.6 Middle East Dengue Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Dengue Vaccines Market Key Performance Indicators |
14 Global Dengue Vaccines Market - Export/Import By Countries Assessment |
15 Global Dengue Vaccines Market - Opportunity Assessment |
15.1 Global Dengue Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Dengue Vaccines Market Opportunity Assessment, By Vaccine, 2021 & 2031F |
15.3 Global Dengue Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
15.4 Global Dengue Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
15.5 Global Dengue Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Dengue Vaccines Market - Competitive Landscape |
16.1 Global Dengue Vaccines Market Revenue Share, By Companies, 2024 |
16.2 Global Dengue Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here